Meeting: 2018 ASCO Annual Meeting Track: Gastrointestinal (Colorectal) Cancer Abstract number: 3505 Authors: Filippo Pietrantonio, Federica Morano, Salvatore Corallo, et. al. Background: Since doublets plus anti-EGFRs were continued until progressive disease (PD) in mCRC first-line registration trials, there is scarce evidence if de-escalating treatment intensity after an anti-EGFR-based induction might be...
Pro zobrazení tohoto obsahu je třeba být přihlášen.